Kuacon 2021
Kuacon 2021
Kuacon 2021
Dear members,
Due to Covid pandemic, 26th KUACON which was scheduled on October 30th and 31st
2021, at Shivamogga was cancelled due to various logistics and statutory reasons.
Hence KUA Executive Council decided to conduct this year’s Annual Conference
virtually.
These two days of annual scientific feast will cover various aspects of Urology and
life.
You are aware that due to the global pandemic the activities of the association were
limited and all the programs were conducted virtually and was well received by all of
you.
On a personal note, I sincerely thank all the members of KUA for providing me an
opportunity to serve the association. I also thank Dr Naveen HN, the Hon. Secretary
and other council members for their valuable support.
Dr Bharath Kshatri
President KUA
Dear members,
The Shivamogga team were planning to have a grand 26th KUACON but due to various
reasons they were unable to conduct physical conference, hence KUA Council 2020-21
planned to have virtual conference as per the schedule dates of 30th and 31st October
2021.
As technology advanced during the pandemic, the conduct of virtual conference is also
advanced. This years, virtual conference is on a 2D platform with interface of human
and machine incorporating near normal experience of a physical meet. KUA Council is
taking all efforts to make it a memorable event by including all the mandatory KUA
programs.
Our eminent scientific review committee have reviewed various abstracts and have
chosen best scientific presentations. Orators for this year Prof. P. Venugopal oration
and MP Raju MYSOGUS endowment lecture are pioneers in their field and are
renowned Indian born international speakers.
Various guest lectures covering different aspects of Urology and life, spirituality,
healthy mind and healthy body will be the highlights of the conference.
I request all the KUA members, to join us and make this 26th KUACON a success.
Jai Karnataka
Regards
3.00 pm to 3.20 pm: Devon Travelling Fellowship Quiz Program (only for PG’s)
3.30 pm to 3.35 pm: Welcome address by Dr. Bharat Kshatri, President KUA
1. Rare sites of delayed metastasis in renal cell carcinoma: A case series of five
patients
Dr Anshuman Singh, Dr. Arun Chawla, Dr. Padmaraj Hegde, KMC Manipal.
3. The Catastrophic Journey of Post Renal Allograft Bleeding: From Hell to Shell.
Dr Sriramadasu Yashwanth, Dr Amruthraj Gowda, Dr Vijay Kumar R, Dr Ravikumar B
R, Dr Sachin D, Dr Manjunath V. JSSMC, Mysuru.
6.00 am to 7.00 am: Stay healthy and stay fit. Health is wealth
Kindly upload 1-minute video/selfie of your work outs like walkathon 2 km, cycolthon
10 km, running 5 km and WhatsApp to 7874337673, # KUACON 2021. Best
video/selfie along with best messages #KUACON 2021 shall receive a prize.
2.OAB score: A clinical tool that predicts the probability of presenting overactive
detrusor in the urodynamic study
3. Modified USS PROM for DVIU and Non Transecting Urethroplasty for Short Bulbar
Urethral Strictures
11.00 am to 12.00 noon: General body meeting (only for full members)
E-poster/free poster Zone, Hourly quiz program award, selfie Zone , best
selfie award, best work out/message award, longest virtual conference screen
time attendee ( based on the hourly quiz question answers) member award.
KUA COUNCIL 2020-21
Dr. Manohar CS
Rare sites of delayed metastasis in renal cell carcinoma: A case series of five
patients
Dr Anshuman Singh, Dr. Arun Chawla, Dr. Padmaraj Hegde, KMC Manipal.
Renal cell carcinoma (RCC) is a lethal malignancy with a propensity for metastatic
spread to any part of the body. The common sites of metastases from RCC include
lungs, adrenals, intestines and brain and most intra- abdominal organs which may
present as synchronous or metachronous to the primary tumour. A long follow-up is
advised to deal with the risk of delayed metastases even when the primary has
been well controlled. There have been few case reports in regard to rare sites of
RCC metastasis. In this series of five cases, we present five rarest sites of
metastatic RCC reported after 5 years of the primary malignancy. Five cases of
solitary metastatic lesion with unknown primary were evaluated and later diagnosed
as metastatic RCC. They were evaluated retrospectively and found to be diagnosed
with RCC more than 5 years back. The solitary metastatic lesions in the 5 patients
were noted in right sartorius muscle, right atrium, posterior wall of bladder, shaft
of right tibia and right third distal phalanx. Metastatis in right sartorius muscle
was managed with wide local excision while the rest four cases were managed by
palliative targeted therapy with sunitinib. 4 patients were doing well at 1 year of
follow up while one patient expired during the course of hospital stay. Isolated
metastasis occurring after many years and at rare sites stresses the need for long
and careful follow-up in the patients treated by radical nephrectomy.
The Catastrophic Journey of Post Renal Allograft Bleeding: From Hell to Shell.
Methods : We present a case of renal cell carcinoma involving Right kidney with tumor
thrombus extending into both venae cavae. Triphasic contrast-enhanced
computerized tomography (CECT) scan of abdomen with three-dimensional
reconstruction showed duplicated left sided IVC. Heterogeneously enhancing
intraluminal soft tissue density filling defect was seen along the entire length of
right renal vein, also crossing the midline to the left sided duplicated IVC -s/o tumour
thrombus. Patient underwent right radical nephroureterectomy with tumour
thrombectomy. Cavotomy was done at the junction of right renal vein and right IVC.
Results:Entire thrombus was delivered intact. Histopathological examination showed
papillary renal cell carcinoma (type II) stage pT3bN1Mx. IVC thrombus showed
clusters of malignant cells of same morphology as tumor entangled in thrombus. The
patient is doing well at 3 months of follow-up.
Conclusion:The recognition of congenital IVC anomalies has major clinical implications.
In addition to preventing diagnostic errors, careful interpretation of cross-sectional
imaging can help to avoid complications arising from venous anomalies unexpectedly
encountered during surgery.
The aim of this study was to compare the disease severity, prognosis and outcome
post treatment in patients of EPN with and without concomitant urolithiasis.
A retrospective comparative study was performed on prospectively kept database
of patients of emphysematous pyelonephritis admitted in Kasturba Hospital from
2016 to 2021. Diagnosis of EPN was established by the presence of gas on CT scan
after ruling out prior instrumentation and fistulous communication with
gastrointestinal tract. The patients were divided into group 1 and group 2 on basis
of presence or absence of urolithiasis respectively. Parameters associated with
disease severity were collected from the medical records and compared between
the two groups. After the initial conservative management of EPN, the stones were
managed appropriately. Descriptive statistics were calculated using the median for
all continuous variables and percentages for all categorical variables. Difference
between means of continuous variables was analysed using two-tailed t-test.
Categorical variables were analysed utilizing the Fisher Exact test. Total 102
patients having EPN were included in the study . 26 patients had concomitant
urolithiasis (group 1) while 76 were with EPN alone (group 2). There was a
statistically significant difference in the peak renal dysfunction [S. Creat 3.5
(Group 1) vs 4.7 (group 2) p < 0.05]; duration of ICU stay [ 7 days (group1) vs 11days
( group 2 ) p < 0.05]; duration of hospital stay [ 9days (group 1) vs 12days (group 2)
p < .05 ]; CT grading severity index [ 32%( grade 1) , 68 ( grade 2 and above ) in
group 1 , 11% (grade1) , 89% ( grade 2 and above ) in group 2 ] ; intervention in the
form of dj stenting/pcn/pcd was done in [ 18 patients (69%) of group 1 and 39
patents (51%) of group 2 ]. No significant difference was observed in total
leucocyte count , associated comorbidities, platelet count between the two groups.
Mortality (11.8%) was present only in the non stone group. 7 (26.9%) patients in the
urolithiasis group underwent elective PCNL and 4 (14%) patients underwent elective
URSL after 4 weeks of discharge. Nephrectomy was needed in 2 (2.6%) patients of
the non-urolithiasis group. EPN associated with urolithiasis had milder course with
excellent response to endourological management as compared to EPN without
concomitant urolithiasis. ICU stay and overall hospital stay was shorter in the EPN
with urolithiasis group. Mortality was observed only in the EPN without urolithiasis
group.
Modified USS PROM for DVIU and Non Transecting Urethroplasty for Short
Bulbar Urethral Strictures.Dr Arun Kumar Chawla. KMC, Manipal.
Introduction and objective- Percutaneous nephrolithotomy is safe and eff ective for
management of large renal calculi. Howev er after PCNL 10% to 35% of patients
mount a systemic infl ammatory response with a small percent progressing to sepsis.
Due to potentially devastating morbidity as well as the 25% to 50% mor tality rate
associated with sepsis, patients with SIRS o ften incur prolonged hospitalization and
higher health care costs. Since blood cultures are o ften negative in patients with
septic shock, clinicians frequently rely on empirical antibiotic regimens. Cultures
obtained from the renal pelvis and stones may be more helpful to guide treatment.
To fu her investigate this we prospectively determined the correlation between
preoperative and intraoperative cultures, and evaluated factors associated with
post-PCNL SIRS. Methodology- Aft er obtaining institutional review board approval
patients undergoing percutaneous nephrolithotomy from September 2016 to July
2021 were enrolled in the study. Approximately 2 weeks before surgery all patients
underwent urine culture evaluation. Renal pelvic urine was collected by retrograde
ureteral catheter placement or during percutaneous puncture of the pelvicalyceal
system.
Results- a total of 200 patients were included in the age group of 20 to 70 years.
Preoperative bladder urine culture(PBUC) was positive in 22 cases and treated with
culture specific antibiotics before surgical intervention. Renal pevic urine culture was
positive in 32 cases of which 21 had negative PBUC. Most common pathogen was E-
Coli followed by enterococcus, klebsiella and pseudomonas. Of the 200 patients, 20
patients had evidence of systemic inflammatory response syndrome(SIRS) including
3, requiring intensive care.
Inguinal Lymph node dissection (ILND) has an important role in both staging and
treatment of penile cancer. Minimally invasive technologies have been utilized to
perform ILND in penile cancer patients with non-palpable inguinal lymph nodes and
intermediate to high-risk primary tumors, including video endoscopic inguinal
lymphadenectomy (VEIL) and robotic video endoscopic inguinal lymphadenectomy
(RVEIL). Current data suggest that VEIL and RVEIL are feasible and safe with
minimal intra-operative complications. Perhaps the strongest appeal for the use of
minimally-invasive approaches is their faster post-operative recovery and less post-
operative complications. When compared to open technique, VEIL and RVEIL have
similar dissected nodal count, a surrogate metric for oncological adequacy, and a
none-inferior inguinal recurrence rate.Our series has post chemotherapy patients,
numbered 6, 12 groins, who underwent Robotic VEIL, operated 2016 onwards, with
average console time of 153mins (excluding Pelvic Lymph node dissection) and
average LN yield of 14. The mean blood loss is 30ml with 2 post operative lymph
collection. The video illustrates the technique of RVEIL including ports marking,
finger dissection. ports insertion and step by step approach of Inguinal dissection.
Gold Sponsor